The purpose of this commentary is to critically examine the CREST-2 results, discuss their implications for clinical decision-making for asymptomatic carotid artery disease, and guide clinicians ...

Delcath Systems, Inc. announced the publication of a retrospective study reporting outcomes from patients with liver-dominant ...

In a retrospective study evaluating circulating fatty acid synthase (cFAS) as a biomarker for peripheral artery disease (PAD) ...

Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the ...

Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation ...

Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and ...

Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeG ...

Penumbra Inc. announced it has secured CE Mark approval for its Lightning Bolt 12 and Lightning Bolt 6X with Trax. These next-g ...

Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced it has secured a $53 million firs ...

Royal Philips announced the expanded commercial availability of its LumiGuide device guidance across Europe and the United Stat ...

November 25, 2025—Healionics Corporation, a developer of synthetic biomaterial-based medical devices, announced recently that 24-month clinical results for its investigational Stargraft arteriovenous ...

November 24, 2025—AI-Stroke, a France-based Software-as-a-Medical-Device (SaMD) company using artificial intelligence (AI) to develop an “AI neurologist” for pre-CT stroke triage, announced the ...